Finance

Beta
Lists
OMCL:NASDAQ
Omnicell Inc
၄၃.၀၃ US$
+၂.၆၂%
(+၁.၁၀) 1D
၄၃.၀၃ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: ဇူ ၂, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OMCL...
Open
၄၁.၉၁ US$
High
၄၃.၁၃ US$
Low
၄၁.၅၅ US$
Mkt. cap
၁၉၅.၇၀ ဋေ
Avg. vol.
၆.၈၁ သိန်း
Volume
၄.၇၉ သိန်း
P/E ratio
၉၇.၅၄
52-wk high
၅၅.၀၀ US$
52-wk low
၂၆.၈၄ US$
EPS
၀.၄၄ US$
Beta
၀.၉၆
Shares outstanding
၄.၅၅ ကုဋေ
No. of employees
၄ ထောင်
Open
၄၁.၉၁ US$
High
၄၃.၁၃ US$
Low
၄၁.၅၅ US$
Mkt. cap
၁၉၅.၇၀ ဋေ
Avg. vol.
၆.၈၁ သိန်း
Volume
၄.၇၉ သိန်း
P/E ratio
၉၇.၅၄
52-wk high
၅၅.၀၀ US$
52-wk low
၂၆.၈၄ US$
EPS
၀.၄၄ US$
Beta
၀.၉၆
Shares outstanding
၄.၅၅ ကုဋေ
No. of employees
၄ ထောင်
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ နာရီ
Qualcomm (QCOM) Is In Talks To Buy Modular And Push Deeper Into AI
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
Nasdaq (NDAQ): The Most Oversold Strong Buy-Rated Stock to Invest In Now
Business Insider
Business Insider
·
ပြီးခဲ့သည့် ၁ ရက်
Why Goldman has backed away from its forecast for a lost decade in stocks
Yardeni QuickTakes
Yardeni QuickTakes
·
ပြီးခဲ့သည့် ၈ နာရီ
US MARKET CALL: A Bubble In Bubbles?
Profile
Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth. Wikipedia
About Omnicell Inc
CEORandall A. Lipps
Employees၃.၅၂ ထောင်
Foundedစက် ၁၉၉၂
HeadquartersMountain View, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to OMCL in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for OMCL in the last 3 months.
Highest
Current ၄၃.၀၃ US$
၇၀.၀၀ US$ (+၆၂.၆၈%)
Average
၆၅.၀၀ US$ (+၅၁.၀၆%)
Lowest
၅၅.၀၀ US$ (+၂၇.၈၂%)
Analyst
Recommendation
Action
Price target
Projected
Date
Stan Berenshteyn
Wells Fargo
Buy
Maintained
၅၅.၀၀ US$
+၂၇.၈%
07/02/2026
Matt Hewitt
Craig-Hallum
Buy
Maintained
-
-
06/11/2026
Allen Lutz
Bank of America Securities
Buy
Maintained
၇၀.၀၀ US$
+၆၂.၇%
06/11/2026
David Larsen
BTIG
Hold
Maintained
-
-
04/28/2026
Scott Schoenhaus
KeyBanc
Buy
Reiterated
၇၀.၀၀ US$
+၆၂.၇%
04/29/2026
Jessica Tassan
Piper Sandler
Buy
Reiterated
၄၉.၀၀ US$
+၁၃.၉%
02/23/2026
Bill Sutherland
Benchmark Co.
Buy
Maintained
၆၀.၀၀ US$
+၃၉.၄%
02/02/2026
Last report
၂၀၂၆ ဧ ၂၈
Fiscal period
Q1 2026
EPS / Est. (USD)
၀.၅၅ US$ / ၀.၃၃ US$
+၆၆.၀၄%beat
Revenue / Est. (USD)
၃၀.၉၉ ကုဋေ / ၃၀.၄၁ ကုဋေ
+၁.၉၁%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၂၉.၀၆ ကုဋေ
၃၁.၀၆ ကုဋေ
၃၁.၄၀ ကုဋေ
၃၀.၉၉ ကုဋေ
Cost of goods sold
၁၆.၂၉ ကုဋေ
၁၇.၆၁ ကုဋေ
၁၇.၉၁ ကုဋေ
၁၆.၉၅ ကုဋေ
Cost of revenue
၁၆.၂၉ ကုဋေ
၁၇.၆၁ ကုဋေ
၁၇.၉၁ ကုဋေ
၁၆.၉၅ ကုဋေ
Research and development expenses
၂.၁၆ ကုဋေ
၂.၄၀ ကုဋေ
၂.၁၆ ကုဋေ
၂.၁၅ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၉.၈၀ ကုဋေ
၁၀.၂၂ ကုဋေ
၁၀.၆၄ ကုဋေ
၁၀.၂၀ ကုဋေ
Operating expense
၁၁.၉၆ ကုဋေ
၁၂.၆၃ ကုဋေ
၁၂.၈၀ ကုဋေ
၁၂.၃၅ ကုဋေ
Total operating expenses
၂၈.၂၄ ကုဋေ
၃၀.၂၄ ကုဋေ
၃၀.၇၁ ကုဋေ
၂၉.၃၀ ကုဋေ
Operating income
၈.၁၂ သန်း
၈.၂၄ သန်း
၆.၉၂ သန်း
၁.၆၉ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
၁.၀၅ ကုဋေ
၉.၇၀ သန်း
၆.၉၉ သိန်း
၁.၆၉ ကုဋေ
EBT excluding unusual items
၁.၀၅ ကုဋေ
၉.၇၀ သန်း
၇.၂၀ သန်း
၁.၆၉ ကုဋေ
Income tax expense
၄.၈၁ သန်း
၄.၂၄ သန်း
၂.၇၂ သန်း
၅.၅၅ သန်း
Effective tax rate
၄၆.၀၅%
၄၃.၇၁%
၃၈၉.၈၄%
၃၂.၈၁%
Other operating expenses
-
-
-
-
Net income
၅.၆၄ သန်း
၅.၄၆ သန်း
-၂.၀၃ သန်း
၁.၁၄ ကုဋေ
Net profit margin
၁.၉၄%
၁.၇၆%
-၀.၆၅%
၃.၆၇%
Earnings per share
၀.၄၅
၀.၅၁
၀.၄၀
၀.၅၅
Interest and investment income
၃.၄၁ သန်း
၂.၄၈ သန်း
၁.၇၉ သန်း
၇.၈၅ သိန်း
Interest expense
-၁.၀၈ သန်း
-၁.၀၂ သန်း
-၁.၅၁ သန်း
-၇.၃၄ သိန်း
Net interest expenses
၂.၃၃ သန်း
၁.၄၆ သန်း
၂.၈၄ သိန်း
၅.၁၀ သောင်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၂.၂၁ ကုဋေ
၂.၂၅ ကုဋေ
၄.၃၁ ကုဋေ
၃.၀၇ ကုဋေ
Gain or loss from assets sale
၁.၈၁ သိန်း
၁.၁၆ သိန်း
၈.၀၀ သောင်း
၁.၂၂ သိန်း
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more